Immunotherapies Flashcards
(24 cards)
What are immunotherapies based on?
Immunomodulation
either suppression or activation
Therapeutic molecules
- Small molecules: <500 Da, non-protein
- MAb(monoclonal antibodies)
- Therapeutic proteins: EC ligands/receptors e.g IL-2
- Vaccines, IVIG: stim endogenous ab prod or give passive ab dosage
- Immune cell based therapies e.g dendritic cell therapy
Immunotherapies: Main areas of application
- Anti-tumor
- Autoimmunity
- Immunodeficiencies
- Transplantation
- Allergies
- Autoinflamm diseases
MAb= Monoclonal Antibodies
Bind to a specific epitop
Whole or fragment ab
Modified by conjugation- toxins, radioactive substances, binding of cytokines
Used for both suppression and stimulation
Can be bispecific: they can connect the target and effector cell
MAb effector functions
Neutralization
Receptor blocking
Apoptosis through cross reactions
Production of MAb: cell types
Plasma cells
Myeloma cells
Production of MAb plasma cells
No in vitro propagation
Retrieved from spleen of an immunized mouse
Ab production
Production of MAb myeloma cell
Propagation in vitro
No ab production
No HGPRT
No TK
Selection of the MAb
Select the viable clones with hypoxanthine aminopterin
Selection of clones producing the desired abs with immuno tests e.g ELISA, IF
Production of MAb
In vivo
In vitro
Production of MAb: In vivo
Abdominal fluid
Possibility of contamination
Animal welfare considerations
Production of MAb: In vitro
Supernatant
Lower risk of contamination
Similar amounts can be obtained
Labelling antibodies
Fab labelled or
Fc labelled
Labelling antibodies: Fab labelled
Biclonal!
Effector cell and antigen
Fusion protein and antigen
Labelling antibodies: Fc labelled
I think these are used in therapy?
Drugs: tumors, autoimmune Toxin: cytotoxic Cytokine: APC activity up Radioactive substances: diagnostics and tumors Liposome: drug Enzyme: diagnostics Fluorescent dye: diagnostics Biotin: diagnostics
Application od MAb
Research
Diagnostics
Therapy
MAb diagnostics
Targets: bacteria, viruses, antibodies, tumors
Methods: ELISA, immunohistochem, immunofluorescence
MAb therapy
Direct cytotoxicity or cell function modulation
The dangers of MAb therapies
Short term: acute hyperreactivity- anaphylaxis
Long-term: elimination of the adaptive immune response
Solution: genetic engineering to produce humanized MAb
Use of ab fragments
Absence of Fc region reduces nonspecific binding
MAb therapy: Mechanisms of action
Ligand binding Receptor blocking Receptor down reg Depletion Signal induction Apoptosis induction Labelling with toxins or drugs
MAb therapy: areas of application
Inflamm diseases
Autoimmune diseases
Infectious diseases
Tumors
MAb in inflamm diseases
Chronic inflamm-
Psoriasis: combined cytokine neutralization anti-p40 ab
Chron’s disease, sclerosis multiplex: anti-integrin alpha4
MAb in Autoimmune diseases, transplantation, tumours
Before organ transplatation, chronic lymphoid leukemia, T-cell lymphomas
Elimination of mature lymphocytes
Anti CD52 ab
Cancer immunotherapy
Therapeutic vaccination
Active vaccination: injection of tumor antigens
Passive vaccinaiton: injection of ab or cells